☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
HLX02
Henlius Present P-III Data of HLX02 (biosimilar- trastuzumab) at ESMO
September 17, 2020
Henlius Present P-III Data of HLX02 (biosimilar- trastuzumab) at ESMO
September 17, 2020
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China
August 17, 2020
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China
August 17, 2020
Load more...
Back to Home
